Brussels, 25/11/2008 (Agence Europe) - Although interest groups stepped up the pressure last week to assert their views on information for patients and/or the business in medicines, the European Commission again postponed examination of the legislative package on medicine. The latter contains a communication and three directives on 1) information for patients, 2) the fight against counterfeiting and 3) pharmacovigilance (EUROPE 9767 and 9763).
If Günter Vergeheugen's (European commissioner...